Financial markets

NeoGames Announces Closing of $94.0 Million Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option

Retrieved on: 
Tuesday, November 24, 2020

The offering consisted of 2,987,625 ordinary shares offered by the Company and 2,541,025 ordinary shares offered by certain selling shareholders.

Key Points: 
  • The offering consisted of 2,987,625 ordinary shares offered by the Company and 2,541,025 ordinary shares offered by certain selling shareholders.
  • The shares began trading on The Nasdaq Global Market under the ticker symbol NGMS on November 19, 2020.
  • Stifel acted as the lead bookrunner for the offering and as representative of the underwriters, and Macquarie Capital and Truist Securities acted as joint bookrunners for the offering.
  • NeoGames pioneering game studio encompasses an extensive portfolio of engaging online lottery games that deliver an entertaining player experience.

CanWel Building Materials Group Ltd. Announces Normal Course Issuer Bid

Retrieved on: 
Tuesday, November 24, 2020

CanWel intends to purchase for cancellation up to 5,972,461 of its common shares by way of a normal course issuer bid through the facilities of the TSX and other Canadian marketplaces and alternative trading systems.

Key Points: 
  • CanWel intends to purchase for cancellation up to 5,972,461 of its common shares by way of a normal course issuer bid through the facilities of the TSX and other Canadian marketplaces and alternative trading systems.
  • Although CanWel intends to purchase common shares for cancellation under its normal course issuer bid, there can be no assurances that any such purchases will be completed.
  • CanWel believes that the market price of the common shares may, at certain times throughout the duration of the normal course issuer bid, be undervalued based solely on CanWels opinion.
  • The Company did not acquire any common shares pursuant to the normal course issuer bid that commenced on November 26, 2019 (the "2019 NCIB").

Where Food Comes From, Inc. Announces 1-for-4 Reverse Stock Split and Intention to List its Shares on the Nasdaq Stock Market

Retrieved on: 
Tuesday, November 24, 2020

The Board of Directors and management are pleased to announced plans to uplist our shares to the Nasdaq Capital Market, said John Saunders, chairman and CEO of WFCF.

Key Points: 
  • The Board of Directors and management are pleased to announced plans to uplist our shares to the Nasdaq Capital Market, said John Saunders, chairman and CEO of WFCF.
  • At the Annual Meeting of Stockholders on May 13, 2019, WFCF stockholders approved a reverse stock split of not more than 1-for-4 as determined by the WFCF Board.
  • The primary purpose of the reverse split is to raise the Companys share price to a level that meets the initial listing standards of the Nasdaq Capital Market.
  • The reverse split would result in each stockholder owning one share of stock for every four shares of stock previously owned.

Monro, Inc. Declares Quarterly Cash Dividend

Retrieved on: 
Tuesday, November 24, 2020

The dividend is payable on December 22, 2020 to shareholders of record at the close of business on December 8, 2020.

Key Points: 
  • The dividend is payable on December 22, 2020 to shareholders of record at the close of business on December 8, 2020.
  • The predecessor to the Company was founded by Charles J. August in 1957 as a Midas Muffler franchise.
  • The Company has experienced significant growth in recent years through acquisitions and, to a lesser extent, the opening of newly constructed stores.
  • The Company went public in 1991 and trades on The Nasdaq Stock Market under the symbol MNRO.

Rocket Pharmaceuticals Announces Participation at Upcoming Conferences

Retrieved on: 
Tuesday, November 24, 2020

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (Rocket), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces participation at the following upcoming conferences:

Key Points: 
  • Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (Rocket), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces participation at the following upcoming conferences:
    Gaurav Shah, M.D., President and CEO, is scheduled to participate in a fireside chat on Wednesday, December 2, 2020, at 3:30 p.m. Eastern Time.
  • A live audio webcast of the presentation will be available on the Investors section of the companys website, www.rocketpharma.com .
  • A replay of the presentation will be archived on the Rocket website following the conferences.
  • Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (Rocket) is advancing an integrated and sustainable pipeline of genetic therapies that correct the root cause of complex and rare childhood disorders.

ICE Benchmark Administration expands ICE Term SONIA Reference Rates methodology to include Tradeweb’s Dealer to Client data

Retrieved on: 
Tuesday, November 24, 2020

Intercontinental Exchange, Inc. (NYSE:ICE), a leading operator of global exchanges and clearing houses and provider of mortgage technology, data and listings services, announces that ICE Benchmark Administration Limited (IBA) has expanded the input data used in its ICE Term SONIA Reference Rates Waterfall methodology to include Tradewebs dealer to client data.

Key Points: 
  • Intercontinental Exchange, Inc. (NYSE:ICE), a leading operator of global exchanges and clearing houses and provider of mortgage technology, data and listings services, announces that ICE Benchmark Administration Limited (IBA) has expanded the input data used in its ICE Term SONIA Reference Rates Waterfall methodology to include Tradewebs dealer to client data.
  • In July 2020, IBA launched an initial, beta version of its ICE Term SONIA Reference Rates (ICE TSRR).
  • We are pleased that ICE has chosen to include Tradeweb data in its Waterfall methodology for Term SONIA Reference Rates, said Lisa Schirf, Managing Director, Global Head of Data Strategy at Tradeweb.
  • ICE TSRR beta rates are published daily on the ICE Term Risk Free Rates (RFR) Portal , a comprehensive data source for market participants of risk free and alternative reference rates.

DGAP-News: publity AG brings 'digital twin' of the PREOS share onto the Blockchain

Retrieved on: 
Tuesday, November 24, 2020

The initial issue price per PREOS token is EUR 9.25 (XETRA closing price of the PREOS share on 23 November 2020).

Key Points: 
  • The initial issue price per PREOS token is EUR 9.25 (XETRA closing price of the PREOS share on 23 November 2020).
  • The PREOS shares required for the transaction originate from the stake of the Frankfurt-based publity AG, which currently holds around 86 percent of the PREOS shares.
  • From an economic point of view, the sale of the tokens backed by PREOS shares is thus similar to a public re-placement of PREOS shares by publity AG.
  • By issuing the PREOS token on the Ethereum Blockchain, publity AG intends to emphasise its technological pioneering role and broaden the PREOS shareholder base by addressing new investor groups, says Nils von Schoenaich-Carolath, Director Treasury & Digital Assets of publity AG and project manager for the PREOS token.

Quincy Data and McKay Brothers Deliver Lowest Latency Between the Largest US Futures Exchanges

Retrieved on: 
Tuesday, November 24, 2020

OAKLAND, Calif., Nov. 24, 2020 /PRNewswire/ -- Quincy Data and McKay Brothers today announced that they have connected the largest US futures exchanges at the lowest latency.

Key Points: 
  • OAKLAND, Calif., Nov. 24, 2020 /PRNewswire/ -- Quincy Data and McKay Brothers today announced that they have connected the largest US futures exchanges at the lowest latency.
  • The new services link the two largest US futures exchanges, which are based in Aurora and Chicago Illinois.
  • The Quincy Raw Data (QRD) service distributes the raw exchange futures feed for crude, natural gas and the S&P 500 futures.
  • The QRD service is the lowest latency market data service between the three largest US equity exchanges, as well as the two largest US futures exchanges.

PayBito Brings Forth Crypto Portfolio Management System for Seamless Portfolio Tracking

Retrieved on: 
Tuesday, November 24, 2020

The cutting-edge crypto portfolio management system is leveraged by the leading institutional Crypto participants, such as brokerage, funds, and digital assets platforms, to streamline the method of running and maintaining the cryptocurrency portfolios.

Key Points: 
  • The cutting-edge crypto portfolio management system is leveraged by the leading institutional Crypto participants, such as brokerage, funds, and digital assets platforms, to streamline the method of running and maintaining the cryptocurrency portfolios.
  • Speaking about PayBito's portfolio management system with the media, Raj Chowdhury , Managing Director of PayBito, commented, "PayBito's Crypto portfolio management system makes a notable difference in a way that traders and investors manage their asset portfolio.
  • My team has developed a cutting-edge crypto portfolio management tracker that helps monitor trade orders as well as asset allocation."
  • What PayBito's portfolio management system has to offer:
    PayBito's portfolio management system comes with a host of advanced features, such as:
    1.

SHAREHOLDER ALERT: WeissLaw LLP Reminds UROV, CIT, HLIX, and CBLI Shareholders About Its Ongoing Investigations

Retrieved on: 
Tuesday, November 24, 2020

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors ofUrovant Sciences Ltd. (NASDAQ: UROV)in connection with the proposed interested-party acquisition of the company by Sumitovant Biopharma Ltd., UROV's majority shareholder that currently owns 72% of the company's outstanding common shares.

Key Points: 
  • WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors ofUrovant Sciences Ltd. (NASDAQ: UROV)in connection with the proposed interested-party acquisition of the company by Sumitovant Biopharma Ltd., UROV's majority shareholder that currently owns 72% of the company's outstanding common shares.
  • Under the terms of the acquisition agreement, the company's shareholders will receive only $16.25 in cash for each share of UROV common stock that they own.
  • If you own UROV shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/urov/
    WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CIT Group Inc. (NASDAQ: CIT)in connection with the proposed acquisition of the company by First Citizens BancShares, Inc. ("FCNCA").
  • Under the terms of the agreement, CIT shareholders will receive 0.0620 shares of FCNCA common stock for each share of CIT common stock that they own, representing implied per-share merger consideration of $33.88 based upon FCNCA's November 20, 2020 closing price of $546.43.